Tegument proteins of Epstein-Barr virus: Diverse functions, complex networks, and oncogenesis

por Murata, Takayuki
Publicado 2023

Epstein-Barr virus: the molecular virology and the associated diseases

por Murata, Takayuki
Publicado 2023

Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival

por Murata, Takayuki
Publicado 2021

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency

por Murata, Takayuki, Tsurumi, Tatsuya
Publicado 2013

IFITM1 enhances nonenveloped viral RNA replication by facilitating cholesterol transport to the Golgi

por ISHIKAWA-Sasaki, Kumiko, Murata, Takayuki, Sasaki, Jun
Publicado 2023

Growth behavior of bovine herpesvirus-1 in permissive and semi-permissive cells

por Murata, Takayuki, Takashima, Yasuhiro, Xuan, Xuen, Otsuka, Haruki
Publicado 1999

Human Rotavirus Reverse Genetics Systems to Study Viral Replication and Pathogenesis

por Komoto, Satoshi, Fukuda, Saori, Murata, Takayuki, Taniguchi, Koki
Publicado 2021

Epstein-Barr virus genome packaging factors accumulate in BMRF1-cores within viral replication compartments

por Sugimoto, Atsuko, Yamashita, Yoriko, Kanda, Teru, Murata, Takayuki, Tsurumi, Tatsuya
Publicado 2019

Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma

por Kimura, Hiroshi, Okuno, Yusuke, Sato, Yoshitaka, Watanabe, Takahiro, Murata, Takayuki
Publicado 2021

Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation

por Nishitsuji, Hironori, Iwahori, Satoko, Ohmori, Mariko, Shimotohno, Kunitada, Murata, Takayuki
Publicado 2022

Serine 13 of the human cytomegalovirus viral cyclin-dependent kinase UL97 is required for regulatory protein 14-3-3 binding and UL97 stability

por Iwahori, Satoko, Umaña, Angie C., Kalejta, Robert F., Murata, Takayuki
Publicado 2022

Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells

por Sato, Yoshitaka, Ochiai, Shingo, Murata, Takayuki, Kanda, Teru, Goshima, Fumi, Kimura, Hiroshi
Publicado 2017

EBV Exploits RNA m(6)A Modification to Promote Cell Survival and Progeny Virus Production During Lytic Cycle

por Yanagi, Yusuke, Watanabe, Takahiro, Hara, Yuya, Sato, Yoshitaka, Kimura, Hiroshi, Murata, Takayuki
Publicado 2022

Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release

por Uddin, Md Kamal, Watanabe, Takahiro, Arata, Masataka, Sato, Yoshitaka, Kimura, Hiroshi, Murata, Takayuki
Publicado 2023

Epstein-Barr virus infection-induced inflammasome activation in human monocytes

por Torii, Yuka, Kawada, Jun-ichi, Murata, Takayuki, Yoshiyama, Hironori, Kimura, Hiroshi, Ito, Yoshinori
Publicado 2017

The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation

por Yoshida, Masahiro, Watanabe, Takahiro, Narita, Yohei, Sato, Yoshitaka, Goshima, Fumi, Kimura, Hiroshi, Murata, Takayuki
Publicado 2017

5′-O-Masked 2′-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents

por Ikejiri, Masahiro, Ohshima, Takayuki, Kato, Keizo, Toyama, Masaaki, Murata, Takayuki, Shimotohno, Kunitada, Maruyama, Tokumi
Publicado 2007

Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers

por Murata, Takayuki, Sakurai, Aki, Suzuki, Masahiro, Komoto, Satoshi, Ide, Tomihiko, Ishihara, Takuma, Doi, Yohei
Publicado 2021

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation

por Murata, Takayuki, Sugimoto, Atsuko, Inagaki, Tomoki, Yanagi, Yusuke, Watanabe, Takahiro, Sato, Yoshitaka, Kimura, Hiroshi
Publicado 2021

Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity

por Masud, H. M. Abdullah Al, Yanagi, Yusuke, Watanabe, Takahiro, Sato, Yoshitaka, Kimura, Hiroshi, Murata, Takayuki
Publicado 2019